Decoding 4 Analyst Evaluations For Owens & Minor

Analysts' ratings for Owens & Minor OMI over the last quarter vary from bullish to bearish, as provided by 4 analysts.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 0 4 0 0
Last 30D 0 0 1 0 0
1M Ago 0 0 0 0 0
2M Ago 0 0 2 0 0
3M Ago 0 0 1 0 0

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $25.0, along with a high estimate of $28.00 and a low estimate of $20.00. The average price target has stayed the same, reflecting a consistent view from analysts.

price target chart

Decoding Analyst Ratings: A Detailed Look

An in-depth analysis of recent analyst actions unveils how financial experts perceive Owens & Minor. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Eric Coldwell Baird Lowers Neutral $20.00 $24.00
Eric Coldwell Baird Lowers Neutral $24.00 $28.00
Daniel Ford Citigroup Raises Neutral $28.00 $24.00
Eric Coldwell Baird Raises Neutral $28.00 $24.00

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Owens & Minor. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Owens & Minor compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Owens & Minor's stock. This comparison reveals trends in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Owens & Minor's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Owens & Minor analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Discovering Owens & Minor: A Closer Look

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Owens & Minor: Delving into Financials

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Owens & Minor displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 3.56%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: Owens & Minor's net margin excels beyond industry benchmarks, reaching -0.84%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Owens & Minor's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.41%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): Owens & Minor's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.42%, the company showcases efficient use of assets and strong financial health.

Debt Management: Owens & Minor's debt-to-equity ratio stands notably higher than the industry average, reaching 2.72. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

The Basics of Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!